DrugDashboards

Chlorothiazide Sodium

Chlorothiazide Sodium · CHLOROTHIAZIDE SODIUM 500 mg/18mL · Injection, Powder, Lyophilized, For Solution · Intravenous · Sun Pharmaceutical Industries, Inc.

NDC 47335-0330-40 · 1 VIAL, SINGLE-DOSE in 1 CARTON / 18 mL in 1 VIAL, SINGLE-DOSE · ANDA · View full market →

The short version

5 companies supply this market — a reasonable cushion if one runs into trouble. One of its named manufacturing plants, Immacule Lifesciences Private Limited, failed FDA inspectionwithin the last two years — the agency’s most serious outcome.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Estimated fill cost

WAC per package, as filed
$99.80
Reported to Texas DSHS · 2026 annual filing · Sun Pharma

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicare Part B (ASP)

Payment limit per 500 MG
$77.771
HCPCS J1205 · Jul 1, 2026 quarter · typically ASP + 6%

Medicaid spend (2022)

$29,808
127 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
ANDA091546
TE code
AP
Approval date
Jul 26, 2011
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Chlorothiazide Sodium (Injection, Powder, Lyophilized, For Solution)

LabelerStrengthFirst seenLast seen
Fresenius Kabi USA, LLCCHLOROTHIAZIDE SODIUM 500 mg/18mLJul 15, 2026Sep 3, 2026
American Regent, Inc.CHLOROTHIAZIDE SODIUM 500 mg/18mLJul 15, 2026Sep 2, 2026
Gland Pharma LimitedCHLOROTHIAZIDE SODIUM 500 mg/18mLJul 15, 2026Sep 2, 2026
Sun Pharmaceutical Industries, Inc.CHLOROTHIAZIDE SODIUM 500 mg/18mLJul 15, 2026Sep 2, 2026
Sagent PharmaceuticalsCHLOROTHIAZIDE SODIUM 500 mg/18mLJul 15, 2026Aug 31, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Chlorothiazide Sodium — NDC 47335-0330-40," retrieved September 3, 2026, https://drugdashboards.com/drug/47335033040.

Free to cite with attribution — see how the data is put together.